Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 7, 2014 - Issue
Submit an article Journal homepage
71
Views
2
CrossRef citations to date
0
Altmetric
Review

Clinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disorders

Florence CF ChangMovement Disorders Unit, Department of Neurology, Westmead Hospital, Sydney Medical School, University of Sydney, Sydney, NSW, Australia
&
Victor SC FungMovement Disorders Unit, Department of Neurology, Westmead Hospital, Sydney Medical School, University of Sydney, Sydney, NSW, AustraliaCorrespondence[email protected]
Pages 317-328 | Published online: 13 Oct 2014

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Daniel O. Claassen, Michael Philbin & Benjamin Carroll. (2019) Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington’s disease: a review of clinical trial data. Expert Opinion on Pharmacotherapy 20:18, pages 2209-2221.
Read now

Articles from other publishers (1)

E. E. Vaiman, N. A. Shnayder, N. G. Neznanov & R. F. Nasyrova. (2020) Candidate genes involved in the development of antipsychotic-induced tardive dyskinesia in patients with schizophrenia. Neuromuscular Diseases 10:3, pages 10-26.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.